Pentadecarginine

Pentadecarginine is an arginine salt formulation of BPC-157, the well-studied body protection compound pentadecapeptide. By pairing the BPC-157 peptide with an L-arginine counter-ion rather than the traditional acetate salt, this formulation is designed to enhance aqueous solubility and potentially improve bioavailability. L-arginine itself serves as a precursor to nitric oxide (NO) via the nitric oxide synthase pathway, and since BPC-157's mechanism of action is known to involve NO system modulation, the arginine salt form may offer complementary activity through enhanced NO substrate availability.

The core peptide retains the same 15-amino acid sequence as standard BPC-157, and therefore the extensive preclinical literature supporting BPC-157's activity in wound healing, gastrointestinal cytoprotection, and tissue repair is directly applicable. Research on BPC-157 has demonstrated its effects on angiogenesis via VEGF upregulation, tendon and ligament healing through improved collagen fiber organization, and neuroprotective activity through modulation of dopaminergic pathways. The arginine salt formulation represents a pharmaceutical chemistry optimization rather than a novel peptide entity.

The rationale for arginine salt formulation draws on research demonstrating that counter-ion selection can significantly influence peptide stability, solubility, and absorption characteristics. Arginine-based salt forms have been explored across pharmaceutical chemistry for their favorable pH buffering properties and their role in NO-mediated vasodilation, which may facilitate tissue distribution of the active peptide.